Rate of venous thromboembolism and atrial fibrillation in a real-world case series of advanced cancer patients: the CaTEV Study
Conclusion
This study showed for cancer patients a considerably higher incidence of VTE and a comparable incidence of atrial fibrillation than reported in literature. Validated thromboembolic risk scores appear to be poorly predictive, and LMWH remains the most widely used anticoagulant drug.
Source: Journal of Cardiovascular Medicine - Category: Cardiology Tags: Research articles: Arrhythmias Source Type: research
More News: Arrhythmia | Atrial Fibrillation | Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Chemotherapy | Heart | Italy Health | Statistics | Study | Thrombosis